Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- MindMaze Therapeutics Reports New Home-Based Rehabilitation Results Ahead of MindMotion Lite LaunchMulti-site Program Demonstrates Threefold Increase in Rehabilitation Training Dose, With 84% Delivered Independently and Significant Improvements Across Functional Measures GENEVA, SWITZERLAND - October 14, 2026 - MindMaze Therapeutics (SIX: MMTX), a global leader in scalable precision neurotherapeutics, today announced new real-world evidence from a multi-site program conducted with Vibra Healthcare, presented yesterday at the American Congress of Rehabilitation Medicine (ACRM) in Washington, DC. The program demonstrated that home-based rehabilitation using MindMotion increased total motor-training dose by a median factor of three compared with usual outpatient therapy alone. 84% of active training was completed independently, without direct therapist supervision. Participants also showed statistically significant improvements in functional independence, balance, mobility and cognition, alongside high patient satisfaction. Building on previously reported inpatient results with Vibra Healthcare, the findings further support MindMaze Therapeutics' strategy to extend high-dose, high-intensity neurorehabilitation into patients' homes. This is particularly relevant to the Company's upcoming launch of MindMotion Lite, expected by year-end 2026. Recently announced, the tablet-based solution is designed to deliver the full range of MindMotion GO neurotherapeutic activities with substantially reduced hardware requirements, simplifying home deployment and supporting broader adoption by healthcare providers. “Earlier this year, we showed that MindMaze's high-dose, high-intensity therapy, integrated into inpatient rehabilitation, delivers superior functional outcomes in a resource-efficient way,” said Zach Henderson, CEO of MindMaze Therapeutics. “Now, we are demonstrating that this value can extend into the home to address a well-recognized gap in care once patients leave the clinic, in line with the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery. These results, combined with our upcoming MindMotion Lite tablet-based solution, will help make high-quality neurotherapeutics more accessible. Together, these milestones bring us closer to our mission of making neurotherapeutics available at scale.” Study Design and Results The retrospective, multi-site quality improvement program evaluated 177 rehabilitation episodes involving 172 adults with a range of neurological conditions, primarily stroke, across four Vibra Healthcare outpatient sites, without a control group. Participants followed an eight-week home-training program using MindMotion GO, with an optional four-week extension and periodic therapist supervision. Key findings included: Training dose: Patients completed an average of 174 minutes of active training per week, with 84.4% delivered asynchronously. The additional home training increased total motor-training dose by a median factor of 3.0 compared with usual outpatient therapy alone, based on published assumptions for active practice during usual care. Feasibility and engagement: 92.7% successfully completed home setup, while 80.2% achieved the predefined minimum training exposure. Among surveyed participants, 83.8% of satisfaction ratings were positive. Functional outcomes: Statistically significant pre–post improvements were observed in independence (Barthel Index: +10.4 points), balance (Berg Balance Scale: +10.5 points), cognition (SLUMS: +3.4 points) and mobility (Timed Up and Go: −8.8 seconds) among participants with available paired assessments. The full poster, High-Dose, Home-Based Neurorehabilitation Using Gamified Technology: A Multi-Site Quality Improvement Program, is available at mindmazetherapeutics.com/mindmaze-platform/clinical-evidence. About MindMaze Therapeutics MindMaze Therapeutics (SIX: MMTX) is a global leader in scalable, precision neurotherapeutics, dedicated to redefining the recovery trajectory for patients around the world. By integrating advanced software, proprietary sensors, and AI-driven data analytics, MindMaze Therapeutics provides a seamless continuum of care from the acute hospital phase to outpatient treatment to home-based therapy. The company's FDA-listed and CE-marked products are designed to address the systemic shortage of specialized clinicians, offering scalable, reimbursable solutions for stroke, Parkinson's disease, and other neurological disorders. With an extensive library of rigorous clinical validation, MindMaze Therapeutics is operationalizing the future of neurorestorative medicine. For more information, visit www.mindmazetherapeutics.com. Media & Investor Contacts Jeremy Meinen, Chief Financial Officer [email protected] DISCLAIMER This press release contains forward-looking statements, which may be identified by words such as "believe," "assume," "expect," "intend," "may," "could," "will," or similar expressions. These statements are based on current plans and assumptions and are subject to risks and uncertainties that could cause actual results, financial condition, performance, or achievements to differ materially from those expressed or implied. This communication is provided as of the date hereof, and MindMaze Therapeutics undertakes no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise. Additional features: File: Press release_MindMaze_Home-Based Rehabilitation Results
- Mutares Portfolio Company Nord Gas Solutions Benefits From a Booming Market; 2026 Revenue Expected to Exceed EUR 575m, With Record Order Backlog of EUR 880m; Strategic Exit Options Under ReviewStrong order backlog: New orders for liquefied gas carriers, ammonia fuel supply systems, floating LNG infrastructure, biogas liquefaction and emissions recovery reflect strong demand for NGS technologies and drive total order backlog to a record high of EUR 880 million. Surging demand driven by converging industry trends, including rising global energy demand, a global focus on securing reliable energy supply and the continued focus on long-term decarbonization, energy transition and efficiency. Clear visibility on 2026 and 2027 performance: Management of NGS expects revenues of over EUR 575 million and adjusted EBITDA of approximately EUR 50 million for the full year 2026 and is confident of achieving double-digit annual revenue growth and a double-digit adjusted EBITDA margin in the full year 2027. Standalone operations and profitability: Developing strategic initiatives across the NGS’s three business areas, together with harnessing the significant growth potential in the aftermarket business serving each business area, and implementing improvements in operational efficiency, have been key priorities since the acquisition by Mutares. Strategic exit alternatives under evaluation: Mutares is evaluating potential strategic exit alternatives for NGS together with its financial advisors, including a potential public listing in the Nordics. MUNICH, GERMANY - October 14, 2026 - Mutares SE & Co. KGaA (ISIN: DE000A2NB650) (“Mutares”) announces that its portfolio company Nord Gas Solutions (“NGS”), a leading independent specialist in gas handling, fuel supply, regasification and liquefaction systems, has experienced surging demand for its gas solutions, including through new project awards, since its acquisition by Mutares. NGS was formed from the Wärtsilä Gas Solutions business and is headquartered in Asker, Norway, with around 500 employees and nine locations worldwide. NGS is a global technology leader in gas solutions, providing gas and energy technologies to international shipyards, gas producers, energy infrastructure developers and industrial customers. Its main operational centers are located in Norway, Sweden and Poland. Peter Wagner, CEO of NGS, comments: “Since becoming an independent company, we have materially grown our order backlog, which now stands at EUR 880 million. Our customers are investing in new gas infrastructure, and we are well positioned to deliver on our targets for 2026 and 2027.” The growth of NGS is underpinned by three converging megatrends. Global energy demand is rising rapidly, driven in part by the expansion of AI and data-center capacity, and is driving a new investment cycle in LNG and gas infrastructure, shipping and regasification. At the same time, heightened geopolitical tension has sharpened the focus on securing reliable and diversified energy supply, increasing demand for energy security and fast-to-deploy solutions such as floating infrastructure. Finally, the continued focus on long-term decarbonization, energy transition and efficiency is creating demand for lower-emission gas solutions. Together, these trends are driving demand for NGS technologies across the gas value chain. NGS: Strong progress in operational development In the first nine months of 2026, NGS generated revenues of approximately EUR 459 million (PY: EUR 283 million) and adjusted EBITDA[1] of EUR 43 million (PY: EUR 20 million). As of 30 September 2026, NGS holds total assets of EUR 493 million, including a very strong cash position of EUR 194 million, a reported net cash position[2] of EUR 84 million and has no financial indebtedness. Total annual revenues of NGS for the 2026 financial year are expected to exceed EUR 575 million, generating an adjusted EBITDA of approximately EUR 50 million. Since the acquisition, Mutares has worked with the management of NGS to initiate and successfully implement targeted measures to strengthen NGS’s operational performance and strategic positioning. These measures reinforce its strong market position across the gas solutions value chain and support the expansion of aftermarket and service revenues. Improved sales and project execution support commercial effectiveness and operational efficiency, driving margin development. NGS: Strong order backlog NGS’s position is reflected in its fixed order backlog, which stood at EUR 880 million as of 30 September 2026, alongside an additional pipeline of potential projects amounting to EUR 1.8 billion. NGS’s core marine business area remains a substantial part of the order book, while midstream infrastructure is growing rapidly. In marine, NGS was awarded a contract in August 2026 to supply cargo-handling and LPG fuel-supply systems for eight new liquefied gas carriers for BW LPG, each with a capacity of 90,000 m³. The vessels will be built at HD Hyundai, further strengthening the longstanding cooperation with the shipbuilding group and BW LPG. A further order, signed in June 2026, covers corresponding systems for two liquefied gas carriers for Byzantine Maritime, each with a capacity of 40,000 m³, with delivery scheduled for April 2027. For the full year 2027, the management of NGS is confident of achieving a year-on-year double-digit revenue increase alongside a double-digit adjusted EBITDA margin, given that approximately 92% of planned 2027 revenue is already covered by NGS’s fixed order backlog as of 30 September 2026. The business of NGS is also on track to achieve its mid-term targets of over EUR 800 million in annual revenue and an adjusted EBITDA of over EUR 100 million. NGS: Growth opportunities from midstream infrastructure and services business areas Midstream infrastructure is a key growth engine for NGS, led by floating storage and regasification unit (“FSRU”) projects, where project scope is increasing and customers are moving towards full conversion scope. NGS is supplying the regasification module for Excelerate Energy’s conversion of the LNG carrier “Methane Patricia Camila” into an FSRU, with delivery planned for the first half of 2028, and has received an additional order from Exmar for a regasification system for a conversion project related to the expansion of the EemsEnergyTerminal in the Netherlands. These projects reflect NGS’s established position in international LNG import infrastructure, and the use cases for its midstream technology are broadening. For the Texas GulfLink project in the United States, NGS is supplying volatile organic compound (VOC) recovery systems for two specially designed offshore support vessels, which capture emissions during crude oil loading and allow the recovered substances to be reused. In ammonia cracking, NGS and Höegh Evi have completed the first phase of performance testing of a pilot plant that converts ammonia into hydrogen, achieving a hydrogen purity of more than 99.5%. Alongside this, NGS is placing a strong focus on its high-margin services and aftermarket business, where management sees substantial potential. With an installed base of more than 1,600 systems worldwide, NGS is well placed to grow recurring revenues from field services, maintenance, spare parts, retrofits and digital services. Strategic alternatives Mutares is evaluating potential strategic exit alternatives for NGS, including a potential public listing in the Nordics in the coming months. No final decision has been made, and there can be no assurance that or at what point in time any transaction will occur. Mutares has strong confidence in NGS's prospects and, in the event of a potential public listing, expects to remain a significant shareholder, subject to customary lock-up arrangements. Company profile of Mutares SE & Co. KGaA Mutares SE & Co. KGaA, Munich (www.mutares.com),is a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Tokyo, Vienna and Warsaw, that acquires companies in transition that show significant potential for operational improvement and are resold after stabilization and repositioning. Mutares pursues a sustainable minimum dividend policy. The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol “MUX” (ISIN: DE000A2NB650) and are included in the SDAX selection index. Disclaimer This announcement does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction. No decision has been made, and there can be no assurance that or at what point in time any transaction will occur. This announcement contains forward-looking statements based on current expectations and assumptions of the management of NGS and Mutares, which are subject to known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that may or may not occur in the future, whether or not outside the control of the relevant company. Accordingly, forward-looking statements are not guarantees of future performance and the development of the relevant company’s prospects, growth, strategies, industry and the effect of acquisitions may differ materially from those made in or suggested by the forward-looking statements contained in this announcement. In addition, even if the development of the relevant company’s prospects, growth, strategies and industry are consistent with the forward-looking statements contained in this announcement, those developments may not be indicative of the relevant company’s results, liquidity or financial position or of results or developments in subsequent periods not covered by this announcement. Forward-looking statements should therefore not be relied upon as predictions of future events. Actual results may differ materially from those expressed or implied. Neither NGS nor Mutares undertake any obligation to update forward-looking statements. For more information, please contact: Mutares SE & Co. KGaA Investor Relations Phone: +49 89 9292 7760 Email: [email protected] www.mutares.com Press Contact in Germany CROSS ALLIANCE communication GmbH Susan Hoffmeister Phone: +49 89 125 09 0333 Email: [email protected] www.crossalliance.de Press Contact in France VAE SOLIS COMMUNICATIONS Marie-Caroline Garnier Phone: +33 6 22 86 39 17 Email: [email protected] Press Contact in the UK and the US 14:46 Consulting Tom Sutton Phone: +44 7796 474940 Email: [email protected] [1] Adjusted EBITDA - Adjusted EBITDA is operating profit before depreciation, amortization and impairment, adjusted for items affecting comparability, such as carve-out, restructuring and transaction-related costs and other one-off items (including one-off bonuses). It is an alternative performance measure and is not defined by IFRS. [2] Reported net cash is defined as cash and cash equivalents, plus contract assets and receivables from group companies, less borrowings and contract liabilities.
- PicPay Payment Institution S/APicPay to Participate in Money 20/20 USA 2026 in Las VegasCEO Eduardo Chedid to lead fireside chat; PicPay to host lunch on Brazil’s next chapter in real-world AI
- GMEX Robotics Completes Initial Strategic Investment in MediaMeta.Ai to Advance Socially Intelligent RoboticsAcquisition of 30% equity interest and exclusive technology access strengthens GMEX’s Terminal + Brain (Intelligence) platform; consideration mix shift to more equity with 24-month lockup aligns long-term interests
- Versus Systems (VS) Leadership Highlights Drinkfinger Expansion and AI Approach in Stock2Me PodcastVersus Systems, a leading provider of gamification and audience engagement technology, integrates Drinkfinger into its growing product marketing offerings. Drinkfinger uses QR-enabled beverage carriers to connect live-event attendees with mobile games, rewards and branded content. The company is targeting Latin American markets, where sports and entertainment events provide potential venues for interactive audience engagement. Versus’ Winfinite platform offers customizable web-based games that brands can use in promotional campaigns. Its Filter Fan Cam product brings augmented-reality effects into live venue experiences, creating additional sponsorship opportunities. Management also discussed the relationship between artificial intelligence and cybersecurity as Versus considers the future of its digital engagement ecosystem. LOS ANGELES, CA - October 14, 2026 - Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, is expanding its audience-engagement strategy through Drinkfinger, a QR-enabled beverage carrier initiative that links live-event attendees to interactive digital experiences. CEO Luis Goldner and members of the company’s leadership team outlined the initiative, its Latin American expansion plans and the company’s approach to artificial intelligence during a recent appearance on IBN’s Stock2Me Podcast. The discussion focused on how Versus can turn a routine concession purchase into an entry point for digital interaction. Through Drinkfinger, fans scan a QR code on a beverage carrier to access games, promotional offers and event-related content on their phones. The approach is designed to reduce the steps between encountering a brand at a venue and participating in a… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer The latest news and updates relating to VS are available in the company’s newsroom at https://ibn.fm/VSI Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
- Wrap Technologies (WRAP) Expands Beyond a Single Device as Public Safety Moves Toward Integrated EcosystemsResearch cited in the article indicates that 1,314 people were killed by police in the United States last year, highlighting the complexity of public safety encounters. WRAP(R) is expanding its approach to Non-Lethal Response(TM) by connecting its platform with scenario-based training, evidence management and emerging threat-detection systems. The appointment of veteran law enforcement instructor John “Chappy” Chapman underscores the company’s focus on standardized training, instructor credentialing and broader agency adoption. LOS ANGELES, CA - October 14, 2026 - Public safety agencies are no longer looking for a single device to solve a single problem. As encounters become more complex and difficult to assess, conversation is increasingly shifting toward connected ecosystems that link technology, training and accountability. Wrap Technologies (NASDAQ: WRAP), a Miami-based public safety technology company, is building its business around this shift, with a portfolio spanning remote restraint, virtual reality training, body-worn cameras and evidence management, as well as its newer detection-and-response platform, WrapShield(TM). The challenges facing officers are well documented. Research cited in the article indicates that police killed approximately 1,314 people in the United States last year. One in five of those people reportedly showed symptoms of mental or behavioral health issues, while 89% of the deaths followed a call for service. A Statista breakdown of the same data indicates that 45% of… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
- Janice Dolnick Highlights Ethical Considerations for AI Use in Legal Nurse ConsultingLegal Forensic Nursing Expert Calls for Human Clinical Judgment, Responsible Billing and Careful Review as AI Enters Medical-Legal Casework
- SS Innovations International (SSII) Submits FDA Response for SSi Mantra Surgical Robotic SystemLOS ANGELES, CA - October 14, 2026 - SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that it submitted its response to a request for additional information from the U.S. Food and Drug Administration (FDA) on Oct. 5, 2026, regarding its 510(k) submission for the SSi Mantra surgical robotic system. The response includes final data from an expanded human clinical and human factors validation study, as well as a bridging study completed in August 2026 at Hospital Internacional de Colombia, a member of the Mayo Clinic Care Network. The submission covers the initial indication of cholecystectomy, or gallbladder removal. The company anticipates that the FDA will complete its review of the response and 510(k) submission in the first quarter of 2027, advancing its efforts to introduce the SSi Mantra system to the U.S. market. To view the full press release, visit https://ibn.fm/A6dJ8 About SS Innovations SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates. About the SSi Mantra The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
- Cassie HourIs Cassie Hour the First Novel to Give AI a Soul?Everyone gave artificial intelligence tasks. Alp Şahin gave it meaning. His literary mystery novel became an artificial world. Now he proposes that inherited meaning can give AI the beginnings of consciousness and soul ISTANBUL, Oct. 14, 2026 -- Strategist and novelist Alp...
- Carrier LogisticsCarrier Logistics and LSP44 Join Forces to Solve AI Bot FatigueCollaboration enables automated LTL shipment tracking for carriers, shippers and 3PLs ELMSFORD, N.Y., Oct. 14, 2026/PRNewswire/ -- Carrier Logistics (CLI), a leading provider of freight management software for Less-Than-Truckload (LTL) fleets, announced today a collaboration with LSP44, a...
- Hesai TechnologyBuilding the Data Infrastructure for Physical AI: Hesai Launches Kosmo 3D World Data EngineHesai Group (Nasdaq: HSAI; HKEX: 2525) ("Hesai" or the "Company"), a Physical AI infrastructure company, today launched Kosmo, a 3D world data engine built to solve one of the most critical bottlenecks in Physical AI: access to high-quality...
- Oro Inc.Eight OroCommerce Customers Named Finalists at the 2026 B2B eCommerce Industry AwardsThe recognition includes 11 finalist placements spanning manufacturing, distribution, AI innovation, customer experience, and individual achievement